Table 1.
Feature | Liver-on-a-Chip (LoC) | Precision-Cut Liver Slice (PCLS) | Liver Organoids | References |
---|---|---|---|---|
Structure | Microfluidic platforms with engineered liver tissues | Thin slices of liver tissue | 3D structures derived from stem cells or primary cells | [66,67,68,69] |
Cellular Composition |
Hepatocytes, endothelial cells, stellate cells | Retains native liver architecture and cell diversity | Hepatocyte-like cells, cholangiocytes, stellate cells | [64,66,73] |
Mimicking In Vivo Environment |
Dynamic fluid flow simulating blood circulation | Maintains cell–cell and cell–matrix interactions | 3D environment with cell–cell and cell–ECM interactions | [68,69,70,81] |
Scalability | Moderate, dependent on microfabrication techniques | Limited by size of initial tissue slice | High, scalable to large numbers | [80,92] |
Duration of Viability |
Days to weeks | Hours to days | Weeks to months | [68,69,93] |
Cost | Moderate, but depends on tissue source | Moderate, but depends on tissue source | Variable, depending on source and differentiation protocol | [80] |
Reproducibility | High with standardized protocols | Thin slices of liver tissue | High with standardized differentiation protocols | [67,69,79] |